LONDON--(BUSINESS WIRE)--Technavio has been monitoring the radiopharmaceuticals market and it is poised to grow by USD 3.58 billion during 2020-2024, progressing at a CAGR of 10% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Please Request Free Sample Report on COVID-19 Impact
The market is concentrated, and the degree of concentration will accelerate during the forecast period. Bayer AG, BWX Technologies Inc., Cardinal Health Inc., Curium, Eckert & Ziegler AG, Eli Lilly and Co., General Electric Co., Lantheus Holdings Inc., Novartis AG, and Siemens Healthineers AG are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Rising burden of neurological disorders has been instrumental in driving the growth of the market.
Radiopharmaceuticals Market 2020-2024: Segmentation
Radiopharmaceuticals Market is segmented as below:
-
Application
- Diagnostics
- Therapeutic
-
Geography
- North America
- Europe
- APAC
- South America
- MEA
To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR43963
Radiopharmaceuticals Market 2020-2024: Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our radiopharmaceuticals market report covers the following areas:
- Radiopharmaceuticals Market size
- Radiopharmaceuticals Market trends
- Radiopharmaceuticals Market analysis
This study identifies partnerships for the development of radiopharmaceuticals as one of the prime reasons driving the radiopharmaceuticals market growth during the next few years.
Radiopharmaceuticals Market 2020-2024: Vendor Analysis
We provide a detailed analysis of vendors operating in the radiopharmaceuticals market, including some of the vendors such as Bayer AG, BWX Technologies Inc., Cardinal Health Inc., Curium, Eckert & Ziegler AG, Eli Lilly and Co., General Electric Co., Lantheus Holdings Inc., Novartis AG, and Siemens Healthineers AG. Backed with competitive intelligence and benchmarking, our research reports on the radiopharmaceuticals market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
Radiopharmaceuticals Market 2020-2024: Key Highlights
- CAGR of the market during the forecast period 2020-2024
- Detailed information on factors that will assist radiopharmaceuticals market growth during the next five years
- Estimation of the radiopharmaceuticals market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the radiopharmaceuticals market
- Analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of radiopharmaceuticals market vendors
Table Of Contents:
Executive Summary
Market Landscape
- Market ecosystem
- Market characteristics
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Application
- Market segments
- Comparison by Application
- Diagnostics - Market size and forecast 2019-2024
- Therapeutic - Market size and forecast 2019-2024
- Market opportunity by Application
Customer Landscape
- Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- APAC - Market size and forecast 2019-2024
- South America - Market size and forecast 2019-2024
- MEA - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
Market Drivers
Market Challenges
Market Trends
Vendor Landscape
- Vendor landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Bayer AG
- BWX Technologies Inc.
- Cardinal Health Inc.
- Curium
- Eckert & Ziegler AG
- Eli Lilly and Co.
- General Electric Co.
- Lantheus Holdings Inc.
- Novartis AG
- Siemens Healthineers AG
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
